Tixagevimab/Cilgavimab for Prevention of COVID-19 during the Omicron Surge: Retrospective Analysis of National VA Electronic Data

Yinong Young-Xu, Lauren Epstein, Vincent C Marconi, Victoria Davey, Gabrielle Zwain, Jeremy Smith, Caroline Korves, Fran Cunningham, Robert Bonomo, Adit A Ginde
doi: https://doi.org/10.1101/2022.05.28.22275716

Article usage

Article usage: May 2022 to November 2024

AbstractFullPdf
May 2022350311820
Jun 202245301951406
Jul 20221877220575
Aug 20221480136424
Sep 2022164887352
Oct 20221313472313
Nov 202296578295
Dec 202272144118
Jan 202348859157
Feb 20234164279
Mar 20233724365
Apr 20232382558
May 20231991629
Jun 20232651226
Jul 2023201635
Aug 20231642231
Sep 20232681521
Oct 20232902663
Nov 20231491521
Dec 202362914
Jan 20247146
Feb 2024871114
Mar 20249017
Apr 2024831215
May 202477849
Jun 2024578011
Jul 2024611113
Aug 2024802218
Sep 2024802814
Oct 20244887
Nov 20243937
Back to top
Posted May 29, 2022.
Download PDF
Data/Code
Email
Tixagevimab/Cilgavimab for Prevention of COVID-19 during the Omicron Surge: Retrospective Analysis of National VA Electronic Data
Yinong Young-Xu, Lauren Epstein, Vincent C Marconi, Victoria Davey, Gabrielle Zwain, Jeremy Smith, Caroline Korves, Fran Cunningham, Robert Bonomo, Adit A Ginde
medRxiv 2022.05.28.22275716; doi: https://doi.org/10.1101/2022.05.28.22275716
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area